Impact Stories

Research Impact Story:
Nathaniel Szewczyk, PhD

Impacting patient care through the study of muscle health

The mission of the Osteopathic Heritage Foundation (the Foundation) is to improve the health and quality of life in the community through education, research and service consistent with our osteopathic heritage. To advance this mission, the Foundation has prioritized investments in scientific research and professional development at leading colleges of osteopathic medicine with the goals of advancing scientific discoveries, healthcare and delivery of patient care.

The Osteopathic Heritage Foundation Ralph S. Licklider, DO Research Endowment supports six research positions at the Ohio University Heritage College of Osteopathic Medicine (Heritage College). The endowment is named in honor of Ralph Licklider, DO, one of the founders of Doctors Hospital in Columbus, Ohio. Dr. Licklider was a board-certified otolaryngologist and served as chair of the Ear, Nose and Throat Department at Doctors Hospital for over three decades.

In 2020, Nathaniel Szewczyk, PhD was appointed to the Osteopathic Heritage Foundation Ralph S. Licklider, DO Endowed Professorship in Molecular Medicine. Dr Szewczyk is a professor and principal investigator at the Heritage College’s Ohio Musculoskeletal and Neurological Institute (OMNI) and his research includes the regulation of muscle health through diet, the environment, physical manipulation and genetics. He is an internationally recognized expert in the role of aging and spaceflight on muscle health, having led and participated in multiple spaceflight experiments funded by the National Aeronautics and Space Administration (NASA) and United Kingdom (UK) Space Agency. His experience studying muscle health in space also earned him positions on working groups for the European Space Agency (ESA) and NASA, where he co-chairs a NASA Open Science Analysis Working Group.

Dr. Szewczyk earned his Doctor of Philosophy degree in cellular, molecular and developmental biology from the University of Pittsburgh and completed post-doctoral studies in space biology with NASA at the Ames Research Center in California. He spent more than 12 years in England teaching Molecular Medicine at the University of Nottingham before joining the Heritage College in 2020. Dr. Szewczyk has authored 99 publications and five book chapters and has received multiple grants from NASA, National Institutes of Health (NIH), the U.S. Army and UK research councils. Dr. Szewczyk is also a committed educator, mentoring students across various departments at Ohio University and helping them gain hands-on research experience and external funding to support their professional growth and career advancement.

Szewczyk lab research students document loading worms for spaceflight at Kennedy Space Center.
Dr. Szewczyk preparing drugs for a worm experiment at Kennedy Space Center.

Investing in the Future of Patient Care

Dr. Szewczyk’s holistic approach embodies osteopathic medicine’s focus on health promotion and disease prevention. His ability to translate findings in the laboratory – both in space and on Earth – is leading to new tools and resources for patient care. His significant contributions to U.S. medical research advances the Foundation’s mission and will change the lives of people living with serious muscle-related diseases and conditions.”

Terri Donlin Huesman, President/CEO

Scientific Discovery:

Advancing scientific understanding of what contributes to muscle health and its role in overall health.

The Future of Patient Care:

Key findings are being used to better understand muscle deterioration associated with disease and aging and to develop new medications and treatments to maintain muscle health.

Dr. Szewczyk spoke with Osteopathic Heritage Foundation staff about his research and the impacts of the Foundation’s investments.

What is your area of research?

Quite simply, muscle. However, muscle is actually quite complex because it is connected to everything and interacts with many systems, organs and cells in the body. Most people think of muscle as structural and essential to how the body moves, but it is also an important tissue for metabolic function, which is the body’s process for converting food and nutrients into energy. For example, muscle plays an important role in metabolizing glucose and Type 2 diabetes can develop when muscle is unable to carry out this function. Through our research, we want to understand why muscle may or may not be able to do this and many other vital functions.

In our research, we study two aspects of muscle: how the substances muscle makes – proteins, DNA and RNA – contribute to its structural and metabolic function and how muscle changes over time. More specifically, we are interested in the maintenance of muscle and how it preserves its function. In the lab, we study how external factors, such as temperature, medicine, exercise and glucose affect muscle. We also study how different conditions like aging, level of activity or a disease process like muscular dystrophy – a disease characterized by progressive weakness and loss of muscle mass – affect muscle.

We know a person loses 7-10% of muscle mass in a week of inactivity; however, a week of activity does not result in regaining 7-10% of muscle mass. Much of our research on the effect of inactivity on muscle is done in space through funding from NASA. In the anti-gravity environment of space, muscle is used differently than on Earth, leading to rapid changes as a result of disuse. As part of our research, we sent worms on three spaceflights to study the rapid changes associated with muscle disuse. Worms have a short lifespan so studies can be conducted more quickly than in other animals or humans and their small size makes them easy to transport and ideal for space experiments. What we observe in these experiments allows us to better understand conditions affecting muscles on Earth.

What scientific discoveries have been made by the Szewczyk lab?

Research in the lab focuses on understanding the molecular mechanisms involved in regulating muscle. This means we look for and study cellular processes contributing to or damaging muscle health and how muscle contributes to overall health. Through our research, the lab has made several foundational discoveries scientists can use to develop new and innovative treatments for conditions and diseases affecting muscle health.
For example, our lab identified signals coming into the cell and controlling protein breakdown in muscle. These signals either support or disable the production of protein. Understanding these signals creates new opportunities for scientists to develop and test innovative treatments for diseases where muscle decline occurs.

Identifying drug targets in muscle cells is another pathway for developing new treatment tools. Drug targets are proteins or other molecules in the body that interact with drugs. Our lab created an index of drug targets in the cell responsible for regulating muscle maintenance. This information can be used to guide the development of new medications to support muscle health in patients and help us understand why some medications cause muscle problems as a side-effect.

Our lab has also developed a way to measure decreases in mitochondria production in muscle cells. The mitochondria are the energy-producing parts of the cell and its production slows with age. Measuring mitochondrion production can also be used to identify early signs of certain diseases, such as muscular dystrophy. This information could be used in the future to develop new diagnostic tests and treatments. For example, we have recently shown in an animal model that increased levels of calcium are an early sign of muscle problems both in muscular dystrophy and with age. We are now examining if and how this translates into people.

You explained your research often uses worm models. How does your work with worms, and in particular, worms on spaceflights, translate to patient care?

The experiments using worms in space are designed to study how the role of genes in muscle change during spaceflight. There are two common changes in muscle cells during spaceflight, one to the metabolic genes responsible for energy production, the other to the cytoskeletal genes, which create the structure of cells and are responsible for cell shape and movement. To evaluate changes in muscle, the maximal strength worms can produce in space is assessed. Strength is also a key measurement of muscle health in people so we can use strength as a way to compare changes in genes that affect strength in worms to those of humans. The muscle and gene changes we observed in worms during spaceflight will now be assessed in astronauts.

If we consider the effect of spaceflight, muscular dystrophy and aging as having similar features of muscle loss, then learning what happens to muscle in one condition allows us to compare what happens in others, eventually leading to new information to guide targeted treatments for disease.

How has the Osteopathic Heritage Foundation’s support helped you advance patient care?

The Foundation’s investment has allowed me to focus on an emerging area of research analyzing multiple genetic and molecular interactions in large-scale datasets. This type of research allows scientists to investigate multiple interactions of cause and effect simultaneously, instead of one at a time. It speeds up the ability to assess and test which conditions affect diseases and gain insights into future clinical applications.
An example of this is a hydrogen sulfide study we conducted related to patients with Duchenne muscular dystrophy (DMD). DMD is a rare degenerative disorder typically diagnosed in young boys, for which there is no cure. Our data analysis of animal models with DMD, compared to those without, demonstrated the DMD models display sulfide deficits, which can be corrected with a readily available over-the-counter supplement. We hypothesize sulfide levels might be a way to diagnose the severity of DMD in patients. To this end, we have designed a clinical study for patients with DMD and look forward to conducting the study to test our hypothesis.

The research endowment established by the Foundation provided the funding for these studies. This is important because federal funding for rare diseases like DMD is primarily focused on finding a cure, but patients are still suffering from this disease and finding better treatments is important for patient care and quality of life. The findings from these studies are being used to design clinical trials to see if this readily available, over-the-counter supplement will improve muscle health in patients with DMD.

How does conducting your research at a college of osteopathic medicine and the osteopathic profession’s focus on treating the whole person influence your work?

The Heritage College and osteopathic medicine’s holistic approach to education and patient care aligns with the way I approach my work. The study of muscle is holistic. It is about looking at muscle as part of a whole person and understanding how it is affected by changes occurring both within and outside the body. This is the heart of what I do, looking comprehensively and systemically at what factors contribute to the body staying in balance. This is a core tenet of osteopathic medicine – the idea of homeostasis or the optimal functioning of the body needed to stay healthy.

What is next for your research?

I am excited to continue the aging and muscle research and to advance the hydrogen sulfide DMD research to clinical trial. There are also many opportunities to continue to conduct spaceflight experiments to enhance our understanding of muscle loss in space and on Earth. A newer body of research we are partnering on with NASA will investigate the effects of spaceflight on the microbiome, the microbes living in the gut, which are increasingly understood to affect the immune system and overall health.

Nathaniel Szewczyk, PhD
Osteopathic Heritage Foundation Ralph S. Licklider, DO Endowed Professor in Molecular Medicine

Dr. Szewczyk checking worm health prior to launch at Kennedy Space Center.

317 Board

The Athens Hocking Vinton Alcohol, Drug Addiction and Mental Health Services Board (317 Board) is part of Ohio’s county and regional network of agencies responsible for planning, developing, funding and evaluating a community-based system of care for individuals in need of behavioral health and substance use disorder services.

Appalachia Accessible Food Network

In 2013, the Appalachia Accessible Food Network (AAFN) was created to expand and diversify coordinated efforts to measurably increase the availability, affordability and consumption of healthy food among low-income, vulnerable populations in southeastern Ohio.

The Foundation for Appalachian Ohio

The Foundation for Appalachian Ohio (FAO) is a regional community foundation serving Appalachian Ohio’s 32 counties, with a mission to create opportunities for Appalachian Ohio’s citizens and communities by inspiring and supporting philanthropy.

CHOICES for Victims of Domestic Violence

CHOICES is committed to excellence in serving domestic violence victims and survivors in Central Ohio and has served as the sole resource for those seeking shelter in Franklin County for more than four decades.

Hopewell Health Centers

Hopewell Health Centers, Inc. (Hopewell) provides access to affordable, high quality integrated healthcare for all. Designated as a Federally Qualified Health Center, Hopewell provides comprehensive health services throughout southeastern Ohio, regardless of a patient's ability to pay.

Our Lady of Guadalupe Center

Our Lady of Guadalupe Center (OLGC) is a program of Catholic Social Services, which evolved from an immigrant woman’s desire to give back to the Hispanic community in Columbus.

Athens Photographic Project

Athens Photographic Project (APP) is a vibrant community of artists dedicated to using photography as a tool for self-expression, personal growth and community contribution within the journey of mental health recovery.


For more than a decade, the Foundation has partnered with Maryhaven, one of Ohio’s most respected substance use recovery organizations, to continue to improve access to recovery services in Central Ohio.

Dr. Robert Nagele

Development of blood-based diagnostic tests for Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis and Breast Cancer.

Dr. Elizabeth A. Beverly

Pioneering the use of virtual reality to improve the lives of patients with diabetes.

Dr. Andrea Amalfitano

Developing technology to turn viruses into safe, effective and scalable gene therapies.

Dr. Brian Degenhardt

Demonstrating the effectiveness of osteopathic manipulative medicine in patient care

Dr. Nathaniel Szewczyk

Impacting patient care through the study of muscle health

Dr. Brian Clark

Prevention and treatment of age-related muscle weakness and bone fractures.